144 related articles for article (PubMed ID: 35084232)
1. Changes in apparent diffusion coefficient and pathological response in colorectal liver metastases after preoperative chemotherapy.
Eriksson S; Bengtsson J; Torén W; Lätt J; Andersson R; Sturesson C
Acta Radiol; 2023 Jan; 64(1):51-57. PubMed ID: 35084232
[TBL] [Abstract][Full Text] [Related]
2. 3T diffusion-weighted MRI in the response assessment of colorectal liver metastases after chemotherapy: Correlation between ADC value and histological tumour regression grading.
Donati F; Boraschi P; Pacciardi F; Cervelli R; Castagna M; Urbani L; Falaschi F; Caramella D
Eur J Radiol; 2017 Jun; 91():57-65. PubMed ID: 28629572
[TBL] [Abstract][Full Text] [Related]
3. Colorectal liver metastases: ADC as an imaging biomarker of tumor behavior and therapeutic response.
Boraschi P; Donati F; Cervelli R; Pacciardi F; Tarantini G; Castagna M; Urbani L; Lencioni R
Eur J Radiol; 2021 Apr; 137():109609. PubMed ID: 33647779
[TBL] [Abstract][Full Text] [Related]
4. Diffusion-weighted and hepatobiliary phase gadoxetic acid-enhanced quantitative MR imaging for identification of complete pathologic response in colorectal liver metastases after preoperative chemotherapy.
Hosseini-Nik H; Fischer SE; Moulton CA; Karbhase G; Menezes RJ; Gallinger S; Jhaveri KS
Abdom Radiol (NY); 2016 Feb; 41(2):231-8. PubMed ID: 26867904
[TBL] [Abstract][Full Text] [Related]
5. Predicting Treatment Response of Colorectal Cancer Liver Metastases to Conventional Lipiodol-Based Transarterial Chemoembolization Using Diffusion-Weighted MR Imaging: Value of Pretreatment Apparent Diffusion Coefficients (ADC) and ADC Changes Under Therapy.
Lahrsow M; Albrecht MH; Bickford MW; Vogl TJ
Cardiovasc Intervent Radiol; 2017 Jun; 40(6):852-859. PubMed ID: 28357571
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of pretreatment diffusion-weighted magnetic resonance imaging for outcome prediction of colorectal cancer liver metastases undergoing 90Y-microsphere radioembolization.
Schmeel FC; Simon B; Luetkens JA; Träber F; Meyer C; Schmeel LC; Sabet A; Ezziddin S; Schild HH; Hadizadeh DR
J Cancer Res Clin Oncol; 2017 Aug; 143(8):1531-1541. PubMed ID: 28317063
[TBL] [Abstract][Full Text] [Related]
7. The role of pre-treatment diffusion-weighted MRI in predicting long-term outcome of colorectal liver metastasis.
Tam HH; Collins DJ; Brown G; Chau I; Cunningham D; Leach MO; Koh DM
Br J Radiol; 2013 Oct; 86(1030):20130281. PubMed ID: 23995873
[TBL] [Abstract][Full Text] [Related]
8. Prediction of hepatic lymph node metastases based on magnetic resonance imaging before and after preoperative chemotherapy in patients with colorectal liver metastases underwent surgical resection.
Zhu HB; Xu D; Sun XF; Li XT; Zhang XY; Wang K; Xing BC; Sun YS
Cancer Imaging; 2023 Feb; 23(1):18. PubMed ID: 36810192
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the residual tumour of colorectal liver metastases after chemotherapy: diffusion-weighted MR magnetic resonance imaging in the peripheral and entire tumour.
Wagner M; Ronot M; Doblas S; Giraudeau C; Van Beers B; Belghiti J; Paradis V; Vilgrain V
Eur Radiol; 2016 Jan; 26(1):206-15. PubMed ID: 25933743
[TBL] [Abstract][Full Text] [Related]
10. Deep learning-assisted magnetic resonance imaging prediction of tumor response to chemotherapy in patients with colorectal liver metastases.
Zhu HB; Xu D; Ye M; Sun L; Zhang XY; Li XT; Nie P; Xing BC; Sun YS
Int J Cancer; 2021 Apr; 148(7):1717-1730. PubMed ID: 33284998
[TBL] [Abstract][Full Text] [Related]
11. Equivalent cross-relaxation rate imaging and diffusion weighted imaging for early prediction of response to bevacizumab-containing treatment in colorectal liver metastases-preliminary study.
Matsushima S; Sato T; Nishiofuku H; Sato Y; Murata S; Kinosada Y; Era S; Inaba Y
Clin Imaging; 2017; 41():1-6. PubMed ID: 27721090
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of apparent diffusion coefficient in evaluation of colorectal carcinoma hepatic metastases' response to radiofrequency ablation.
Szurowska E; Nowicki TK; Izycka-Swieszewska E; Zadrozny D; Markiet K; Studniarek M
J Magn Reson Imaging; 2013 Nov; 38(5):1027-32. PubMed ID: 23526807
[TBL] [Abstract][Full Text] [Related]
13. Potential of MR histogram analyses for prediction of response to chemotherapy in patients with colorectal hepatic metastases.
Liang HY; Huang YQ; Yang ZX; Ying-Ding ; Zeng MS; Rao SX
Eur Radiol; 2016 Jul; 26(7):2009-18. PubMed ID: 26494642
[TBL] [Abstract][Full Text] [Related]
14. Liver resection for colorectal metastases after chemotherapy: impact of chemotherapy-related liver injuries, pathological tumor response, and micrometastases on long-term survival.
Viganò L; Capussotti L; De Rosa G; De Saussure WO; Mentha G; Rubbia-Brandt L
Ann Surg; 2013 Nov; 258(5):731-40; discussion 741-2. PubMed ID: 24045448
[TBL] [Abstract][Full Text] [Related]
15. Comparison of intravoxel incoherent motion imaging, diffusion kurtosis imaging, and conventional DWI in predicting the chemotherapeutic response of colorectal liver metastases.
Zhang H; Li W; Fu C; Grimm R; Chen Z; Zhang W; Qiu L; Wang C; Zhang X; Yue L; Hu X; Guo W; Tong T
Eur J Radiol; 2020 Sep; 130():109149. PubMed ID: 32659615
[TBL] [Abstract][Full Text] [Related]
16. Value of diffusion weighted MR imaging as an early surrogate parameter for evaluation of tumor response to high-dose-rate brachytherapy of colorectal liver metastases.
Wybranski C; Zeile M; Löwenthal D; Fischbach F; Pech M; Röhl FW; Gademann G; Ricke J; Dudeck O
Radiat Oncol; 2011 Apr; 6(1):43. PubMed ID: 21524305
[TBL] [Abstract][Full Text] [Related]
17. Qualitative and quantitative parameters on hepatobiliary phase of gadoxetic acid-enhanced MR imaging for predicting pathological response to preoperative systemic therapy in colorectal liver metastases.
Gu XL; Cui Y; Wang K; Xing Q; Li XT; Zhu HT; Li ZW; Sun YS
Eur J Radiol; 2022 Dec; 157():110572. PubMed ID: 36327859
[TBL] [Abstract][Full Text] [Related]
18. Identifying response in colorectal liver metastases treated with bevacizumab: development of RECIST by combining contrast-enhanced and diffusion-weighted MRI.
Liu LH; Zhou GF; Lv H; Wang ZC; Rao SX; Zeng MS
Eur Radiol; 2021 Aug; 31(8):5640-5649. PubMed ID: 33449175
[TBL] [Abstract][Full Text] [Related]
19. Diffusion-Related MRI Parameters for Assessing Early Treatment Response of Liver Metastases to Cytotoxic Therapy in Colorectal Cancer.
Kim JH; Joo I; Kim TY; Han SW; Kim YJ; Lee JM; Han JK
AJR Am J Roentgenol; 2016 Sep; 207(3):W26-32. PubMed ID: 27303858
[TBL] [Abstract][Full Text] [Related]
20. Liver metastases from colorectal cancer treated with conventional and antiangiogenetic chemotherapy: evaluation with liver computed tomography perfusion and magnetic resonance diffusion-weighted imaging.
Anzidei M; Napoli A; Zaccagna F; Cartocci G; Saba L; Menichini G; Cavallo Marincola B; Marotta E; Di Mare L; Catalano C; Passariello R
J Comput Assist Tomogr; 2011; 35(6):690-6. PubMed ID: 22082538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
